Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease

The use of TNFα antagonists is well described for inflammatory bowel disease (IBD), but their safety profile during pregnancy is yet to be fully elucidated. A systematic review and meta-analysis were performed to identify studies that explored the safety of anti-TNFα therapy during pregnancy in patients with IBD.A systematic literature search was conducted to identify studies that investigated the pregnancy outcomes among women with IBD on...